
Po-chih Chen
Examiner (ID: 4660, Phone: (571)270-7243 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1626 |
| Total Applications | 924 |
| Issued Applications | 609 |
| Pending Applications | 121 |
| Abandoned Applications | 231 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13551727
[patent_doc_number] => 20180327411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => INDOLE AHR INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/958586
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 108676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 437
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15958586
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/958586 | Indole AHR inhibitors and uses thereof | Apr 19, 2018 | Issued |
Array
(
[id] => 16297648
[patent_doc_number] => 20200283371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => PHARMACEUTICALLY ACCEPTABLE SALT OF ALKYLCARBAMOYL NAPHTHALENYLOXY OCTENOYLHYDROXYAMIDE OR OF DERIVATIVE THEREOF AND METHOD FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 16/616547
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616547
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616547 | Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxy amide or of derivative thereof and method for preparing same | Apr 17, 2018 | Issued |
Array
(
[id] => 16786037
[patent_doc_number] => 10988449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Isoxazole derivatives as nuclear receptor agonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/604180
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36629
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604180
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604180 | Isoxazole derivatives as nuclear receptor agonists and uses thereof | Apr 11, 2018 | Issued |
Array
(
[id] => 16012573
[patent_doc_number] => 20200181129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => CARBAZOLE COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/604532
[patent_app_country] => US
[patent_app_date] => 2018-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604532
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604532 | Carbazole compounds and methods of use thereof | Apr 10, 2018 | Issued |
Array
(
[id] => 17905468
[patent_doc_number] => 11459311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Pharmaceutical composition containing indirubin derivative as active ingredient
[patent_app_type] => utility
[patent_app_number] => 16/606089
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5760
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606089 | Pharmaceutical composition containing indirubin derivative as active ingredient | Apr 9, 2018 | Issued |
Array
(
[id] => 17228562
[patent_doc_number] => 20210355118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => COMPOUNDS AND THEIR METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/500795
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -74
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500795
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500795 | Compounds and their methods of use | Apr 3, 2018 | Issued |
Array
(
[id] => 18186358
[patent_doc_number] => 11576916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Methods of preventing or treating ophthalmic diseases
[patent_app_type] => utility
[patent_app_number] => 16/500504
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17965
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500504 | Methods of preventing or treating ophthalmic diseases | Apr 2, 2018 | Issued |
Array
(
[id] => 16525131
[patent_doc_number] => 20200399211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => ALKYL SULFATE ESTER OR SALT OF SAME
[patent_app_type] => utility
[patent_app_number] => 16/498576
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498576 | Alkyl sulfate ester or salt of same | Mar 29, 2018 | Issued |
Array
(
[id] => 13300159
[patent_doc_number] => 20180201616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
[patent_app_type] => utility
[patent_app_number] => 15/923948
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 1063
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923948
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/923948 | 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | Mar 15, 2018 | Abandoned |
Array
(
[id] => 13357081
[patent_doc_number] => 20180230080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => ADENYLYL CYCLASE INHIBITORS FOR NEUROPATHIC AND INFLAMMATORY PAIN
[patent_app_type] => utility
[patent_app_number] => 15/920654
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15920654
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/920654 | Adenylyl cyclase inhibitors for neuropathic and inflammatory pain | Mar 13, 2018 | Issued |
Array
(
[id] => 17297765
[patent_doc_number] => 20210393604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => NOVEL BENZIMIDAZOLONE COMPOUND AND PHARMACEUTICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/494168
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 1067
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494168
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494168 | NOVEL BENZIMIDAZOLONE COMPOUND AND PHARMACEUTICAL USE THEREOF | Mar 13, 2018 | Abandoned |
| 15/915958 | Solid Forms Comprising an Oxime Ether Compound, Compositions and Methods of Use Thereof | Mar 7, 2018 | Abandoned |
Array
(
[id] => 15407935
[patent_doc_number] => 20200024289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => NOVEL OXABOROLE ANALOGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/489824
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489824 | Oxaborole analogs and uses thereof | Feb 28, 2018 | Issued |
Array
(
[id] => 18964089
[patent_doc_number] => 11897838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => High-purity isothiocyanate compound preparation method for industrial production
[patent_app_type] => utility
[patent_app_number] => 16/489226
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4494
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 307
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489226 | High-purity isothiocyanate compound preparation method for industrial production | Feb 26, 2018 | Issued |
Array
(
[id] => 15360797
[patent_doc_number] => 20200016163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => TREATMENT OF DEMENTIA WITH CANNABINOID AGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/489110
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489110
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489110 | TREATMENT OF DEMENTIA WITH CANNABINOID AGONISTS | Feb 22, 2018 | Abandoned |
Array
(
[id] => 18716461
[patent_doc_number] => 11793782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Therapeutic agents for neurodegenerative diseases
[patent_app_type] => utility
[patent_app_number] => 16/756948
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 53
[patent_no_of_words] => 28369
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756948
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756948 | Therapeutic agents for neurodegenerative diseases | Feb 14, 2018 | Issued |
Array
(
[id] => 18187498
[patent_doc_number] => 11578067
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Compound, and method for producing regulatory T cells
[patent_app_type] => utility
[patent_app_number] => 16/479229
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 18
[patent_no_of_words] => 13008
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16479229
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/479229 | Compound, and method for producing regulatory T cells | Jan 29, 2018 | Issued |
Array
(
[id] => 13342625
[patent_doc_number] => 20180222852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => Synthesis of Methyl Carbamate and Dimethyl Carbonate (DMC) in Presence of Stripping with Inert Gas or Superheated Vapours and a Reactor for the Same
[patent_app_type] => utility
[patent_app_number] => 15/883912
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15883912
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/883912 | Synthesis of methyl carbamate and dimethyl carbonate (DMC) in presence of stripping with inert gas or superheated vapours and a reactor for the same | Jan 29, 2018 | Issued |
Array
(
[id] => 15054699
[patent_doc_number] => 10457638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
[patent_app_type] => utility
[patent_app_number] => 15/875929
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65924
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875929
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/875929 | Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B | Jan 18, 2018 | Issued |
Array
(
[id] => 13051381
[patent_doc_number] => 10047071
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-08-14
[patent_title] => Dihydropyrimidinone derivatives
[patent_app_type] => utility
[patent_app_number] => 15/871927
[patent_app_country] => US
[patent_app_date] => 2018-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3003
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15871927
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/871927 | Dihydropyrimidinone derivatives | Jan 14, 2018 | Issued |